View source for DRd

* Chemotherapy combining [[daratumumab]], [[lenalidomide]] (Revlimid), and [[dexamethasone]] (DRd)
* Cycles are typically 28 days each and involve::
** [[Lenalidomide]] 25 mg PO on Days 1-21 of each 28-day cycle
** [[Dexamethasone]] 40 mg PO weekly
** [[Daratumumab]] 16 mg/kg IV weekly for cycles 1 and 2, q2w for cycles 3-6, then q4w until disease progression
* Indicated for [[multiple myeloma]]

[[Category:Hematology]]
[[Category:Chemotherapy]]